Stan Smith - 27 Dec 2022 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MAIA	Common Stock	Purchase	$2,042	+604	+0.12%	$3.38	510,091	27 Dec 2022	See Footnote	F1, F2
transaction	MAIA	Common Stock	Purchase	$4,317	+1,266	+0.25%	$3.41	511,357	28 Dec 2022	See Footnote	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
F2	The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.29 to $3.485 inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
F3	The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.345 to $3.50, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.